Cite

HARVARD Citation

    Pini, L. et al. (2021). Prospective Italian real‐world study of mepolizumab in severe eosinophilic asthma validates retrospective outcome reports. Clinical and translational allergy. 11 (8), p. n/a. [Online]. 
  
Back to record